| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.53 | 0.0005 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |